Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019
(COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were …

Importance Although effective vaccines against COVID-19 have been developed, additional
vaccines are still needed. Objective To evaluate the efficacy and adverse events of 2 …

Importance A vaccine against coronavirus disease 2019 (COVID-19) is urgently needed.
Objective To evaluate the safety and immunogenicity of an investigational inactivated whole-…

Currently, there are no approved specific antiviral agents for 2019 novel coronavirus disease
(COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test were …

Background We aimed to assess the safety and immunogenicity of an inactivated vaccine
against COVID-19 in Chinese adults aged ≥18 years. Methods This is an ongoing randomized…

Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the
host via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …

Safe and effective vaccines against SARS-CoV-2 for children are urgently needed. Here we
aimed to assess the safety and immunogenicity of an inactivated COVID-19 vaccine …

Poor immune responses to inactivated influenza vaccine can be improved by effective and
safe adjuvants to increase antibody titers and cellular protective response. In our study, …

The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be
long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to …

Influenza prevention and control has been one of the biggest challenges encountered in the
public health domain. The vaccination against influenza plays a pivotal role in the …